Aprepitant for the prevention of chemotherapy‐induced nausea and vomiting in paediatric subjects: An analysis by age group

Background This was a subgroup analysis of age group, dexamethasone use, and very highly emetogenic chemotherapy (VHEC) use from a randomised, multicentre, double‐blind, Phase 3 study of oral aprepitant in paediatric subjects. Methods Subjects aged 6 months to 17 years scheduled to receive chemother...

Ausführliche Beschreibung